Literature DB >> 8354767

The sources of convergence between measures of apathy and depression.

R S Marin1, S Firinciogullari, R C Biedrzycki.   

Abstract

Apathy and depression are discriminable but related dimensions of behavior. The purpose of this study was to evaluate the source of the overlap between measures of apathy and depression. We evaluated the intercorrelations between the Apathy Evaluation Scale (AES) and the Hamilton Rating Scale for Depression (HamD) in 107 subjects, aged 53-85, who met research criteria for normal aging, left or right cerebral hemisphere stroke, probable Alzheimer's disease, or major depression. We determined the correlation between the individual items on the HamD and the total scores on the AES and the HamD. The HamD items having the strongest correlations with AES total score were diminished work/interest, psychomotor retardation, anergy, and lack of insight. The correlation between AES and HamD total scores was nonsignificant when major depression subjects and these variables most closely related to apathy were excluded from consideration. These findings indicate that the convergence between HamD and AES is attributable to (i) a subset of HamD items which are consistent with the syndrome of apathy and (ii) the fact that major depression is associated with both apathy and depression. Clinical and research applications of these results are discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8354767     DOI: 10.1016/0165-0327(93)90040-q

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  33 in total

1.  Demoralization, anhedonia and grief in patients with severe physical illness.

Authors:  David M Clarke; David W Kissane; Tom Trauer; Graeme C Smith
Journal:  World Psychiatry       Date:  2005-06       Impact factor: 49.548

Review 2.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 3.  Are the available apathy measures reliable and valid? A review of the psychometric evidence.

Authors:  Diana E Clarke; Jean Y Ko; Emily A Kuhl; Robert van Reekum; Rocio Salvador; Robert S Marin
Journal:  J Psychosom Res       Date:  2010-03-31       Impact factor: 3.006

4.  Cognitive reserve protects against apathy in individuals with human immunodeficiency virus.

Authors:  Miriam E Shapiro; Jeannette R Mahoney; Deena Peyser; Barry S Zingman; Joe Verghese
Journal:  Arch Clin Neuropsychol       Date:  2013-09-09       Impact factor: 2.813

5.  An appraisal of the psychometric properties of the Clinician version of the Apathy Evaluation Scale (AES-C).

Authors:  Diana E Clarke; Robert Van Reekum; Jigisha Patel; Martine Simard; Everlyne Gomez; David L Streiner
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

6.  Selective monoaminergic and histaminergic circuit dysregulation following long-term HIV-1 protein exposure.

Authors:  Adam R Denton; Srimal A Samaranayake; Kristin N Kirchner; Robert F Roscoe; Shane N Berger; Steven B Harrod; Charles F Mactutus; Parastoo Hashemi; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2019-05-17       Impact factor: 2.643

7.  Observing social gestures: an fMRI study.

Authors:  Kristine M Knutson; Erin M McClellan; Jordan Grafman
Journal:  Exp Brain Res       Date:  2008-05-15       Impact factor: 1.972

Review 8.  The mysterious motivational functions of mesolimbic dopamine.

Authors:  John D Salamone; Mercè Correa
Journal:  Neuron       Date:  2012-11-08       Impact factor: 17.173

9.  Brain microstructure of subclinical apathy phenomenology in healthy individuals.

Authors:  Gianfranco Spalletta; Sabrina Fagioli; Carlo Caltagirone; Fabrizio Piras
Journal:  Hum Brain Mapp       Date:  2012-07-17       Impact factor: 5.038

10.  Apathy correlates with cognitive performance, functional disability, and HIV RNA plasma levels in HIV-positive individuals.

Authors:  Miriam E Shapiro; Jeannette R Mahoney; Barry S Zingman; David L Pogge; Joe Verghese
Journal:  J Clin Exp Neuropsychol       Date:  2013-10-04       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.